Characterization of major and clinically relevant non-major bleeding in the APEX trial

28 August 2018 (15:50 - 16:40)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Miss Megan Yee

Boston (United States of America)

5 More presentations in this session

Presentation thumbnail

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Doctor R. Amiya (Osaka, JP)

Abstract Slides

Presentation thumbnail

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Doctor M. Lamberts (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Doctor M. Proietti (Milan, IT)

Abstract Slides

Presentation thumbnail

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Professor H. Jeong (Iksan, KR)

Abstract Slides

Presentation thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Mr J. Strange (Copenhagen, DK)

Abstract Slides

Access the full session

Session thumbnail

Oral anticoagulants : news from large trials and registries

The Event

ESC Congress 2018

28 August 2018 15:50 CET

You may be interested in

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Antithrombotic therapy in diabetes

Congress Presentation

Contemporary thrombosis management -- state of the state

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources